The article offers the author's views on the use of adenoviral vectors to deliver donor templates for genome editing which facilitates precise genome modifications in human cells, and discusses its implications for both basic and translational applications of rare-cleaving nuclease technologies. It mentions the use of an adenoviral vector to have a repair template for genome editing.